Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2018, Article ID 9679287, 4 pages
Case Report

A Challenging Case of Severe Ulcerative Colitis following the Initiation of Secukinumab for Ankylosing Spondylitis

1Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
2Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA

Correspondence should be addressed to David Padua; ude.alcu.tendem@audapd

Received 21 November 2017; Accepted 18 January 2018; Published 15 February 2018

Academic Editor: Hirotada Akiho

Copyright © 2018 Dean Ehrlich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Ted George Achufusi, Prateek S. Harnee, and Sekou Rawlins, “A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab,” Case Reports in Medicine, vol. 2019, pp. 1–5, 2019. View at Publisher · View at Google Scholar
  • Rafael Rodríguez Moncada, Juan María Vázquez Morón, and Héctor Pallarés Manrique, “The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?,” Revista Española de Enfermedades Digestivas, vol. 111, 2019. View at Publisher · View at Google Scholar